Company Overview of Helix Therapeutics, Inc.
Helix Therapeutics, Inc. develops deoxyribonucleic acid (DNA) based therapeutics. It develops novel sequence-specific gene-targeting reagents for the treatment of HIV/AIDS and common genetic diseases, such as sickle cell anemia, thalassemia, and cystic fibrosis. The company was founded in 2006 and is based in New Haven, Connecticut.
150 Munson Street
25 Science Park
New Haven, CT 06511
Founded in 2006
Key Executives for Helix Therapeutics, Inc.
Similar Private Companies By Industry
|Owl Separation Systems LLC||United States|
|Quigley Pharma, Inc.||United States|
|Nativis, Inc.||United States|
|Cromos Pharma,LLC||United States|
|Algorithme Pharma USA Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Hyattsville, MD | University of Maryland University CollegePosted: Mar 04
- Saint Louis, MO | EnvisionPosted: Feb 13
- South San Francisco, CA | GenentechPosted: Mar 08
- San Mateo, CA |Posted: Mar 06
Sponsored Financial Commentaries
To contact Helix Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.